Kun Ding

546 total citations
15 papers, 407 citations indexed

About

Kun Ding is a scholar working on Molecular Biology, Ophthalmology and Genetics. According to data from OpenAlex, Kun Ding has authored 15 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Ophthalmology and 3 papers in Genetics. Recurrent topics in Kun Ding's work include Retinal Diseases and Treatments (5 papers), Retinal Development and Disorders (4 papers) and Cancer-related molecular mechanisms research (3 papers). Kun Ding is often cited by papers focused on Retinal Diseases and Treatments (5 papers), Retinal Development and Disorders (4 papers) and Cancer-related molecular mechanisms research (3 papers). Kun Ding collaborates with scholars based in China, United States and Netherlands. Kun Ding's co-authors include Jikui Shen, Peter A. Campochiaro, Raquel Lima e Silva, Sean F. Hackett, Mahmood Khan, Christopher D. Kontos, Sean F. Hackett, Huiming Xia, Joseph M. McClung and Aling Dong and has published in prestigious journals such as Journal of Clinical Investigation, Science Advances and Investigative Ophthalmology & Visual Science.

In The Last Decade

Kun Ding

11 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kun Ding China 8 280 189 90 56 52 15 407
Rafiqul Hussain United Kingdom 12 326 1.2× 131 0.7× 50 0.6× 20 0.4× 28 0.5× 25 519
Stephen C. Kulak Canada 10 255 0.9× 73 0.4× 45 0.5× 31 0.6× 81 1.6× 12 419
Lucy J. Dawes United Kingdom 13 323 1.2× 247 1.3× 132 1.5× 37 0.7× 43 0.8× 16 517
Claudia Priglinger Germany 14 257 0.9× 212 1.1× 113 1.3× 20 0.4× 28 0.5× 38 442
Naoyasu Umeda United States 10 264 0.9× 254 1.3× 173 1.9× 33 0.6× 17 0.3× 16 450
Yoko Karasawa Japan 14 152 0.5× 300 1.6× 149 1.7× 20 0.4× 29 0.6× 34 489
Yosuke Ida Japan 15 287 1.0× 234 1.2× 143 1.6× 78 1.4× 36 0.7× 47 585
Leslie M. O’Rourke United States 10 131 0.5× 169 0.9× 86 1.0× 45 0.8× 21 0.4× 13 449
Dallas Shi United States 10 119 0.4× 162 0.9× 65 0.7× 16 0.3× 9 0.2× 12 395
Anna M. Demetriades United States 13 210 0.8× 276 1.5× 152 1.7× 27 0.5× 24 0.5× 21 463

Countries citing papers authored by Kun Ding

Since Specialization
Citations

This map shows the geographic impact of Kun Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Ding more than expected).

Fields of papers citing papers by Kun Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Ding. The network helps show where Kun Ding may publish in the future.

Co-authorship network of co-authors of Kun Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Kun Ding. A scholar is included among the top collaborators of Kun Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Ding. Kun Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Gong, Jian, et al.. (2025). LINC00662 regulates osteogenic differentiation of BMSCs and inhibits fracture healing via miR-330-3p/PTEN axis. BMC Musculoskeletal Disorders. 26(1). 633–633.
3.
5.
Ding, Kun, Jikui Shen, Sean F. Hackett, Mahmood Khan, & Peter A. Campochiaro. (2021). Proteosomal degradation impairs transcytosis of AAV vectors from suprachoroidal space to retina. Gene Therapy. 28(12). 740–747. 7 indexed citations
6.
Wang, Tao, Meng Zhou, Jing Guo, et al.. (2021). Analysis of selection signatures on the Z chromosome of bidirectional selection broiler lines for the assessment of abdominal fat content. BMC Genomic Data. 22(1). 18–18. 5 indexed citations
7.
Wang, Tao, Yuanyuan Guo, Shengwei Liu, et al.. (2021). KLF4, a Key Regulator of a Transitive Triplet, Acts on the TGF-β Signaling Pathway and Contributes to High-Altitude Adaptation of Tibetan Pigs. Frontiers in Genetics. 12. 628192–628192. 11 indexed citations
9.
Shen, Jikui, Stephany Y. Tzeng, Kun Ding, et al.. (2020). Suprachoroidal gene transfer with nonviral nanoparticles. Science Advances. 6(27). 47 indexed citations
10.
Ding, Kun, et al.. (2020). Transgene Expression in RPE and Retina after Suprachoroidal delivery of AAV vectors. 61(7). 4490–4490. 2 indexed citations
11.
Ding, Kun, Jikui Shen, Sean F. Hackett, et al.. (2019). AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression. Journal of Clinical Investigation. 129(11). 4901–4911. 109 indexed citations
12.
Shen, Jikui, Mingbing Zeng, Kun Ding, et al.. (2016). The HIF-1 inhibitor acriflavine is visualized in retina after multiple modes of administration/doses that suppress ocular neovascularization. Investigative Ophthalmology & Visual Science. 57(12). 4537–4537. 1 indexed citations
13.
Zeng, Mingbing, Jikui Shen, Yuanyuan Liu, et al.. (2016). The HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization. Journal of Molecular Medicine. 95(4). 417–429. 41 indexed citations
14.
Shen, Jikui, Maike Frye, Joseph M. McClung, et al.. (2014). Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature. Journal of Clinical Investigation. 124(10). 4564–4576. 162 indexed citations
15.
Zou, Zhiqiang, Yuping Ding, Bo Long, et al.. (2011). Gpc-3 is a notable diagnostic, prognostic and a latent targeted therapy marker in hepatocellular carcinoma.. PubMed. 57(102-103). 1285–90. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026